Study examines medicinal herbs as alternative treatment for COPD, due to unsatisfactory current therapies leading to adverse events like cardiovascular complications. Relevant for improving COPD management in labs.
Study showed GHX02, a herbal extract, effectively reduced inflammation in asthma-rhinitis mice model exposed to fine dust. Potential treatment for asthma patients with rhinitis.
Celastrol from Tripterygium wilfordii roots reduces airway inflammation and hyperresponsiveness in obese asthma by balancing M1/M2 alveolar macrophage polarization, possibly through the PI3K/AKT pathway. This could lead to new therapeutic options for obese asthma.
Researchers studied the pharmacological actions of onion in treating airway diseases like asthma. Natural products like onion may be a safer and more cost-effective alternative to synthetic drugs.
Study on Demethylzeylasteral (T-96) from Tripterygium wilfordii Hook F shows its potential for treating allergic asthma by modulating immune response. Important for future asthma treatments.
Study developed a new method to efficiently screen and isolate potential active ingredients in Inonotus obliquus for treatment of asthma. Utilized UF mass spectrometry and molecular docking to identify inhibitors of 5-LOX, followed by isolation of betulin, lanosterol, and quercetin.
Study finds extract with anti-asthmatic effects, reducing symptoms and improving lung function in rats. Extract shows antioxidant, anti-inflammatory activities and induces autophagy while inhibiting apoptosis. Could be developed as anti-allergic asthma drug.
Researchers studied the medicinal plant Raphanus sativus L., commonly used for inflammation and asthma. Their findings could inform the development of new treatments for these conditions.